Literature DB >> 3017581

The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.

B S Dobozin, F N Judson, D L Cohn, K A Penley, P E Rickmann, M J Blaser, P S Sarin, S H Weiss, C H Kirkpatrick.   

Abstract

A comprehensive evaluation of the cellular immune system (total T-cell, helper cell, suppressor cell, and natural killer cell numbers; in vitro interleukin-2 production, T-cell responses to mitogens and antigens, serum beta 2 microglobulin levels, and delayed hypersensitivity skin tests) was performed on 36 HTLV-III seronegative and 16 HTLV-III seropositive healthy homosexual men, 48 asymptomatic homosexual men with the chronic lymphadenopathy syndrome, 41 patients with AIDS, and 29 heterosexual controls without any known risk factors for AIDS. Our studies demonstrate that HTLV-III seronegative homosexual men have normal cellular immunity and are comparable to heterosexual controls. The abnormalities of lymphocyte subsets observed in HTLV-III seropositive healthy homosexual men are comparable to subjects with chronic lymphadenopathy. Assays of lymphocyte function, with the exception of delayed type hypersensitivity (DTH) skin tests, are similar in each group except patients with AIDS. Subjects with chronic lymphadenopathy were less responsive to DTH skin tests and HTLV-III seropositive healthy homosexuals were comparable to chronic lymphadenopathy subjects. We conclude that immunologic abnormalities in homosexual men are attributable to infection with HTLV-III.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017581     DOI: 10.1016/0008-8749(86)90276-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effects.

Authors:  K M Zunich; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

2.  Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Authors:  J Krowka; D Stites; J Mills; H Hollander; T McHugh; M Busch; L Wilhelm; L Blackwood
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

3.  Bullous impetigo in homosexual men--a risk marker for HIV-1 infection?

Authors:  B Donovan; R Rohrsheim; I Bassett; B P Mulhall
Journal:  Genitourin Med       Date:  1992-06

4.  Immunological responses of Gambians in relation to clinical stage of HIV-2 disease.

Authors:  H Whittle; A Egboga; J Todd; G Morgan; M Rolfe; S Sabally; A Wilkins; T Corrah
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.